Affirm's strong quarter: real progress, but GAAP distortion and rich valuation

What happened

Affirm reported quarterly results that included a one-time tax allowance release, boosting GAAP EPS to $4.62, but the underlying business showed strong momentum with revenue up 33% and GMV up 36% year-over-year. Adjusted operating income grew 49% and margins expanded, driven by stable credit performance and a 103-basis-point reduction in funding costs to 5.8%. The company continues to scale its BNPL platform with high repeat usage and expanding merchant partnerships, though the balance sheet remains leveraged with net debt/EBITDA around 9x and interest coverage below 1x. While the GAAP profit is inflated, the operational improvements are real and support the company's path to sustainable profitability. However, shares trade at over 100 times trailing EPS and more than 200% above a conservative DCF estimate, leaving little margin of safety.

Implication

Investors should view the tax benefit as non-core and focus on the ~33% revenue growth and expanding margins, which demonstrate the scalability of Affirm's model. The 103bp drop in funding costs is a meaningful tailwind that, if sustained, could improve profitability and reduce leverage over time. That said, the company remains highly sensitive to credit cycles and regulatory changes, with sector delinquencies near 30% and BNPL facing potential card-like oversight. The current valuation, at over 100x EPS and ~43x EBITDA, embeds a long runway of flawless execution that leaves little room for error. A disciplined approach would wait for either a meaningful pullback toward intrinsic value or further evidence of deleveraging and regulatory clarity before considering a long position.

Thesis delta

The operational update confirms management's execution on growth and funding costs, reducing near-term credit and funding risk identified in the prior 'POTENTIAL SELL' stance. However, the one-time tax benefit masks true earnings power, and the valuation remains extremely stretched relative to intrinsic value. As a result, the thesis shifts from 'POTENTIAL SELL' to a cautious 'WAIT/HOLD' pending further deleveraging or a price correction.